Biblio Discovery — Demo Discovery Service

17 hasil untuk "Javaheri, Ali"

Menampilkan 1–17 · 0,24 detik · RSS

  1. Artikel Jurnal Teks lengkap

    NO to Lysosomes: A Signal for Insulin Resistance in Obesity

    Javaheri, Ali; Diwan, Abhinav

    Cell Mol Gastroenterol Hepatol · 2019 · Inggris · PubMed Central

  2. Artikel Jurnal Teks lengkap

    Cholesterol efflux in the transplant patient

    Sudarshan, Sangita; Javaheri, Ali

    Curr Opin Endocrinol Diabetes Obes · 2018 · Inggris · PubMed Central

    PURPOSE OF REVIEW: Cholesterol metabolism is increasingly recognized in inflammatory diseases including transplantation. This review discusses the mechanistic underpinnings that tie macrophage cholesterol efflux capacity of high-density lipoprotein to chronic rejection in transplanted patients…

  3. Artikel Jurnal Teks lengkap

    Lysosomes Mediate Benefits of Intermittent Fasting in Cardiometabolic Disease: The Janitor is the Undercover Boss.

    Mani, Kartik; Javaheri, Ali; Diwan, Abhinav

    Compr Physiol · 2018 · Inggris · PubMed Central

    Adaptive responses that counter starvation have evolved over millennia to permit organismal survival, including changes at the level of individual organelles, cells, tissues, and organ systems. In the past century, a shift has occurred away from disease caused by insufficient nutrient supply…

  4. Artikel Jurnal Teks lengkap

    A Survey of Aspirin Knowledge Among the General Public

    Owen, Joshua L.; Rush, J. Logan; Armbrecht, Eric S. dkk.

    J Gen Intern Med · 2021 · Inggris · PubMed Central

  5. Artikel Jurnal Teks lengkap

    Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction

    Adamo, Luigi; Yu, Jinsheng; Rocha-Resende, Cibele dkk.

    J Am Coll Cardiol · 2020 · Inggris · PubMed Central

    BACKGROUND: There is a growing recognition of the inherent limitations of the use of the left ventricular ejection fraction (LVEF) to accurately phenotype patients with heart failure (HF). OBJECTIVES: To identify unique proteomic signatures for patients with HFrEF, HFmrEF and HFpEF, as well as to…

  6. Artikel Jurnal Teks lengkap

    Transcription Factor EB Activation Rescues Advanced αB‐Crystallin Mutation‐Induced Cardiomyopathy by Normalizing Desmin Localization

    Ma, Xiucui; Mani, Kartik; Liu, Haiyan dkk.

    J Am Heart Assoc · 2019 · Inggris · PubMed Central

    BACKGROUND: Mutations in αB‐crystallin result in proteotoxic cardiomyopathy with desmin mislocalization to protein aggregates. Intermittent fasting (IF) is a novel approach to activate transcription factor EB (TFEB), a master regulator of the autophagy‐lysosomal pathway, in the myocardium. We…

  7. Artikel Jurnal Teks lengkap

    Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway

    Liu, Haiyan; Javaheri, Ali; Godar, Rebecca J. dkk.

    Autophagy · 2017 · Inggris · PubMed Central

    Obesity-induced diabetes is characterized by hyperglycemia, insulin resistance, and progressive beta cell failure. In islets of mice with obesity-induced diabetes, we observe increased beta cell death and impaired autophagic flux. We hypothesized that intermittent fasting, a clinically sustainable…

  8. Artikel Jurnal Teks lengkap

    Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID‐19: Design and rationale for the DARE‐19 study

    Kosiborod, Mikhail; Berwanger, Otavio; Koch, Gary G. dkk.

    Diabetes Obes Metab · 2021 · Inggris · PubMed Central

    AIMS: Coronavirus disease 2019 (COVID‐19) is caused by a novel severe acute respiratory syndrome coronavirus 2. It can lead to multiorgan failure, including respiratory and cardiovascular decompensation, and kidney injury, with significant associated morbidity and mortality, particularly in…

  9. Artikel Jurnal Teks lengkap

    Simple nutrients bypass the requirement for HLH-30 in coupling lysosomal nutrient sensing to survival

    Murphy, John T.; Liu, Haiyan; Ma, Xiucui dkk.

    PLoS Biol · 2019 · Inggris · PubMed Central

    Lysosomes are ubiquitous acidified organelles that degrade intracellular and extracellular material trafficked via multiple pathways. Lysosomes also sense cellular nutrient levels to regulate target of rapamycin (TOR) kinase, a signaling enzyme that drives growth and suppresses activity of the…

  10. Artikel Jurnal Teks lengkap

    TFEB activation in macrophages attenuates postmyocardial infarction ventricular dysfunction independently of ATG5-mediated autophagy

    Javaheri, Ali; Bajpai, Geetika; Picataggi, Antonino dkk.

    JCI Insight · 2019 · Inggris · PubMed Central

    Lysosomes are at the epicenter of cellular processes critical for inflammasome activation in macrophages. Inflammasome activation and IL-1β secretion are implicated in myocardial infarction (MI) and resultant heart failure; however, little is known about how macrophage lysosomes regulate these…

  11. Artikel Jurnal Teks lengkap

    Lack of MTTP protein in pluripotent stem cell-derived hepatocytes/cardiomyocytes abolishes apoB secretion and increases cell stress

    Liu, Ying; Conlon, Donna M.; Bi, Xin dkk.

    Cell Rep · 2017 · Inggris · PubMed Central

    Abetalipoproteinemia (ABL) is an inherited disorder of lipoprotein metabolism resulting from mutations in Microsomal Triglyceride Transfer Protein (MTTP). In addition to the liver and intestine, MTTP is expressed in cardiomyocytes and cardiomyopathy has been reported in several ABL cases. Using…

  12. Artikel Jurnal Teks lengkap

    Quantitative Proteomic Analysis of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction

    Hanff, Thomas C.; Cohen, Jordana B.; Zhao, Lei dkk.

    JACC Basic Transl Sci · 2021 · Inggris · PubMed Central

    Diabetes mellitus (DM) is associated with a higher risk of heart failure hospitalization and mortality in patients with heart failure with preserved ejection fraction (HFpEF). Using SomaScan assays and proteomics analysis of plasma from participants in the TOPCAT (Treatment of Preserved Cardiac…

  13. Artikel Jurnal Teks lengkap

    TRAF2, an Innate Immune Sensor, Reciprocally Regulates Mitophagy and Inflammation to Maintain Cardiac Myocyte Homeostasis

    Ma, Xiucui; Rawnsley, David R.; Kovacs, Attila dkk.

    JACC Basic Transl Sci · 2021 · Inggris · PubMed Central

    Mitochondria are essential for cardiac myocyte function, but damaged mitochondria trigger cardiac myocyte death. Although mitophagy, a lysosomal degradative pathway to remove damaged mitochondria, is robustly active in cardiac myocytes in the unstressed heart, its mechanisms and physiological role…

  14. Artikel Jurnal Teks lengkap

    Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis

    Sergin, Ismail; Evans, Trent D.; Zhang, Xiangyu dkk.

    Nat Commun · 2017 · Inggris · PubMed Central

    Macrophages specialize in removing lipids and debris present in the atherosclerotic plaque. However, plaque progression renders macrophages unable to degrade exogenous atherogenic material and endogenous cargo including dysfunctional proteins and organelles. Here we show that a decline in the…

  15. Artikel Jurnal Teks lengkap

    Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure

    Chirinos, Julio A.; Zhao, Lei; Jia, Yi dkk.

    Circulation · 2020 · Inggris · PubMed Central

    BACKGROUND: Apolipoprotein M (APOM) mediates the physical interaction between high-density lipoprotein (HDL) particles and sphingosine-1-phosphate (S1P). APOM exerts anti-inflammatory and cardio-protective effects in animal models. METHODS: In a subset of Penn-HF study (PHFS) participants (n=297)…

  16. Artikel Jurnal Teks lengkap

    Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

    Kosiborod, Mikhail N; Esterline, Russell; Furtado, Remo H M dkk.

    Lancet Diabetes Endocrinol · 2021 · Inggris · PubMed Central

    BACKGROUND: COVID-19 can lead to multiorgan failure. Dapagliflozin, a SGLT2 inhibitor, has significant protective benefits for the heart and kidney. We aimed to see whether this agent might provide organ protection in patients with COVID-19 by affecting processes dysregulated during acute illness…